| Literature DB >> 29180647 |
Varesh Prasad1,2, Maria Guerrisi3, Mario Dauri4,5, Filadelfo Coniglione4,5,6, Giuseppe Tisone7, Elisa De Carolis5, Annagrazia Cillis5, Antonio Canichella3, Nicola Toschi3,8, Thomas Heldt9,10.
Abstract
Major surgeries can result in high rates of adverse postoperative events. Reliable prediction of which patient might be at risk for such events may help guide peri- and postoperative care. We show how archiving and mining of intraoperative hemodynamic data in orthotopic liver transplantation (OLT) can aid in the prediction of postoperative 180-day mortality and acute renal failure (ARF), improving upon predictions that rely on preoperative information only. From 101 patient records, we extracted 15 preoperative features from clinical records and 41 features from intraoperative hemodynamic signals. We used logistic regression with leave-one-out cross-validation to predict outcomes, and incorporated methods to limit potential model instabilities from feature multicollinearity. Using only preoperative features, mortality prediction achieved an area under the receiver operating characteristic curve (AUC) of 0.53 (95% CI: 0.44-0.78). By using intraoperative features, performance improved significantly to 0.82 (95% CI: 0.56-0.91, P = 0.001). Similarly, including intraoperative features (AUC = 0.82; 95% CI: 0.66-0.94) in ARF prediction improved performance over preoperative features (AUC = 0.72; 95% CI: 0.50-0.85), though not significantly (P = 0.32). We conclude that inclusion of intraoperative hemodynamic features significantly improves prediction of postoperative events in OLT. Features strongly associated with occurrence of both outcomes included greater intraoperative central venous pressure and greater transfusion volumes.Entities:
Mesh:
Year: 2017 PMID: 29180647 PMCID: PMC5703992 DOI: 10.1038/s41598-017-16233-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(A) Overview of data collection and outcome prediction procedure. Data were collected and extracted from medical records and intraoperative hemodynamic monitors. Prediction of each outcome was carried out in four separate tasks with different groups of features after performing subset selection within each feature group. In each task, logistic regression classifiers were constructed with every combination of 5 or fewer features and leave-one-out cross-validation was used for training and testing. (B) Illustration of the three features extracted from each continuously computed hemodynamic signal. In addition to the median and median absolute deviation (MAD), the integrated area of the signal relative to a normal threshold (either above or below the threshold) was computed. For the stroke volume index (SVI) signal here, the area below 40 mL/m2 was computed. Left: a 60-minute portion of one patient’s SVI waveform. Right: the histogram of this signal’s values.
Characterization of overall patient population with univariate group differences. Continuous data are presented as median (interquartile range) and tested for differences between groups by the Wilcoxon rank sum test. Categorical data are presented as counts (%) and tested for differences between groups by the chi-squared test.
| Characteristic | Survival | N | 180-day mortality | N | P-value | No ARF | N | ARF | N | P-value |
|---|---|---|---|---|---|---|---|---|---|---|
| Age | 56 (50–61) | 72 | 57 (51–62) | 26 | 0.729 | 56 (51–62) | 72 | 56 (46–62) | 22 | 0.421 |
| Male | 53 (74.7) | 71 | 18 (72.0) | 25 | 0.795 | 54 (76.1) | 71 | 15 (71.4) | 21 | 0.667 |
| Weight (kg) | 73 (65.0–83.5) | 72 | 75.5 (65.0–84.0) | 26 | 0.961 | 73 (66.0–82.5) | 72 | 74 (60.0–84.0) | 22 | 0.607 |
| Body Mass Index (kg/m2) | 25.9 (22.4–28.2) | 71 | 26 (23.0–27.3) | 26 | 0.845 | 26 (22.7–28.1) | 71 | 24.1 (22.5–27.3) | 22 | 0.292 |
| Diabetes | 16 (22.2) | 72 | 8 (30.8) | 26 | 0.385 | 17 (23.6) | 72 | 7 (31.8) | 22 | 0.44 |
| Hypertension | 22 (30.6) | 72 | 7 (26.9) | 26 | 0.728 | 21 (29.2) | 72 | 6 (27.3) | 22 | 0.864 |
| Smoking | 20 (27.8) | 72 | 6 (23.1) | 26 | 0.642 | 21 (29.2) | 72 | 5 (22.3) | 22 | 0.555 |
| ASA Class | ||||||||||
| 1 | 0 (0) | 51 | 0 (0) | 18 | 0.770 | 0 (0) | 51 | 0 (0) | 15 | 0.690 |
| 2 | 5 (9.8) | 1 (5.6) | 5 (9.8) | 1 (6.7) | ||||||
| 3 | 40 (78.4) | 14 (77.8) | 40 (78.4) | 11 (73.3) | ||||||
| 4 | 6 (11.8) | 3 (16.7) | 6 (11.8) | 3 (20.0) | ||||||
| Child-Pugh Score | ||||||||||
| A | 17 (30.9) | 7 (31.8) | 16 (28.1) | 5 (29.4) | ||||||
| B | 22 (40.0) | 8 (36.4) | 24 (42.1) | 5 (29.4) | ||||||
| C | 16 (29.1) | 55 | 7 (31.8) | 22 | 0.953 | 17 (29.8) | 57 | 7 (41.2) | 17 | 0.587 |
| MELD | 18 (11–20) | 72 | 17 (11–20) | 26 | 0.977 | 16 (10–19) | 72 | 20 (16–25) | 22 | 0.006 |
| Piggyback Technique | 30 (41.7) | 72 | 7 (28.0) | 25 | 0.226 | 29 (40.9) | 71 | 7 (31.8) | 22 | 0.448 |
| Marginal Donor | 34 (47.2) | 72 | 10 (38.5) | 26 | 0.441 | 36 (50.0) | 72 | 8 (36.4) | 22 | 0.262 |
| INR | 1.49 (1.20–1.80) | 72 | 1.56 (1.30–1.70) | 26 | 0.454 | 1.48 (1.20–1.73) | 72 | 1.61 (1.39–1.83) | 22 | 0.15 |
| Direct bilirubin (mg/dL) | 1.17 (0.48–1.97) | 68 | 0.91 (0.60–2.35) | 25 | 0.845 | 1.13 (0.48–1.79) | 70 | 1.88 (0.71–4.80) | 20 | 0.066 |
| Total bilirubin (mg/dL) | 1.5 (0.59–3.08) | 70 | 1.54 (0.80–2.64) | 26 | 0.378 | 1.5 (0.66–3.08) | 70 | 1.99 (1.06–4.10) | 22 | 0.144 |
| Albumin (g/dL) | 3.20 (2.90–3.60) | 72 | 2.90 (2.35–3.23) | 25 | 0.007 | 3.20 (2.90–3.60) | 72 | 2.80 (2.40–3.20) | 21 | 0.009 |
| Creatinine (mg/dL) | 0.90 (0.80–1.12) | 72 | 0.90 (0.70–1.50) | 26 | 0.984 | 0.90 (0.80–1.10) | 72 | 1.10 (0.70–2.10) | 22 | 0.131 |
ARF: Acute renal failure.
MELD: model for end-stage liver disease score.
INR: international normalized ratio of prothrombin time.
ASA: American Society of Anesthesiologists.
Lists of pre- and intraoperative features and inclusion by subset selection into the pre-operative, intra-operative, and combined (pre- and intra-operative) feature sets.
|
|
| ||||
|---|---|---|---|---|---|
| Only pre-operative features | Only intra-operative features | Combined features | |||
| Preoperative features | Age [years] | X | X | ||
| Marginal vs. nonmarginal donor | X | X | |||
| Prothrombin time international normalized ratio (INR) | X | ||||
| Serum direct bilirubin [mg/dL] | X | X | |||
| Serum albumin [g/dL] | |||||
| Serum creatinine [mg/dL] | X | X | |||
| Model for end-stage liver disease score (MELD) | |||||
| Classical vs. piggyback surgical technique | X | X | |||
| Male vs. female sex | X | X | |||
| History of diabetes | X | X | |||
| History of hypertension | X | X | |||
| Present smoking status | X | X | |||
| American Society of Anesthesiologists (ASA) class | X | X | |||
| Body mass index (BMI) [kg/m2] | |||||
| Non-hemodynamic intraoperative features | Volume of whole blood administered [mL/kg] | X | |||
| Volume of fresh frozen plasma administered [mL/kg] | X | X | |||
| Volume of platelets administered [mL/kg] | X | X | |||
| Volume of packed red blood cells autotransfused [mL/kg] | X | X | |||
| Overall surgery duration [min] | |||||
| Intraoperative hemodynamic variables and extracted features | Systolic arterial blood pressure (SBP) [mmHg] | Median | |||
| MAD | |||||
| Area below 100 mmHg | X | X | |||
| Central venous pressure (CVP) [mmHg] | Median | ||||
| MAD | X | X | |||
| Area above 5 mmHg | X | X | |||
| Heart rate (HR) [bpm] | Median | ||||
| MAD | X | X | |||
| Area above 100 bpm | X | X | |||
| Peripheral oxygen saturation (SpO2) [%] | Median | ||||
| MAD | X | X | |||
| Area below 90% | X | X | |||
| Cardiac function index (CFI) [min−1] | Median | ||||
| Max left ventricular contractility (dPmx) [mmHg/s] | Median | ||||
| MAD | X | X | |||
| Area below 642 mmHg/s | X | X | |||
| Extravascular lung water index (ELWI) [mL/kg] | Median | ||||
| Global end-diastolic volume index (GEDI) [mL/m2] | Median | ||||
| Global ejection fraction (GEF) [%] | Median | ||||
| Intrathoracic blood volume index (ITBI) [mL/min/m2] | Median | ||||
| Pulse-contour cardiac index (PCCI) [L/min/m2] | Median | ||||
| MAD | X | X | |||
| Area below 3 L/min/m2 | X | X | |||
| Pulse pressure variation (PPV) [%] | Median | ||||
| MAD | |||||
| Area above 10% | X | X | |||
| Pulmonary vascular permeability index (PVPI) | Median | ||||
| Stroke volume index (SVI) [mL/m2] | Median | ||||
| MAD | X | X | |||
| Area above 40 mL/m2 | X | X | |||
| Systemic vascular resistance index (SVRI) [dyn·s·cm−5·m2] | Median | ||||
| MAD | X | ||||
| Area below 1700 dyn·s·cm−5·m2 | X | ||||
| Stroke volume variation (SVV) [%] | Median | ||||
| MAD | X | ||||
| Area above 10% | X | X | |||
AUCs and odds ratios for the best mortality and ARF classifiers.
| Outcome | Possible features | Best AUC (95% CI) | Features included in best classifier | Odds ratios (95% CI) | P-value |
|---|---|---|---|---|---|
| 180-day Mortality | Preoperative | 0.53 (0.44–0.78) | Smoking | 0.204 (0.024–1.739) | 0.146 |
| Hypertension | 0.572 (0.107–3.068) | 0.514 | |||
| Nonmarginal donor | 0.724 (0.189–2.772) | 0.637 | |||
| Intraoperative | 0.82 (0.56–0.91) | MAD dPmx | 0.987 (0.968–1.007) s/mmHg | 0.201 | |
| MAD CVP | 0.399 (0.163–0.979) mmHg−1 | 0.045 | |||
| RBC | 1.095 (1.023–1.171) kg/mL | 0.008 | |||
| Area CVP > 5 mmHg | 1.001 (1.000–1.001) (mmHg·min)−1 | 0.048 | |||
| Combined | 0.81 (0.64–0.94) | Platelets | 1.276 (1.036–1.571) kg/mL | 0.022 | |
| Serum creatinine | 0.026 (0.000–1.646) dL/mg | 0.085 | |||
| Area SVI < 40 mL/m2 | 1.002 (1.000–1.003) (mL·m−2·min)−1 | 0.024 | |||
| MAD dPmx | 0.989 (0.968–1.010) s/mmHg | 0.288 | |||
| Area CVP > 5 mmHg | 1.001 (1.000–1.001) (mmHg·min)−1 | 0.009 | |||
| Blood product volumes and duration | 0.75 (0.56–0.93) | Whole blood | 1.086 (1.030–1.145) kg/mL | 0.002 | |
| Acute Renal Failure | Preoperative | 0.72 (0.50–0.85) | Serum creatinine | 1.928 (1.064–3.494) dL/mg | 0.030 |
| INR | 3.685 (1.093–12.426) | 0.035 | |||
| Intraoperative | 0.76 (0.55–0.87) | Area SBP < 100 mmHg | 1.000 (0.999–1.000) (mmHg·min)−1 | 0.150 | |
| Fresh frozen plasma | 0.932 (0.843–1.031) kg/mL | 0.170 | |||
| MAD SVI | 1.394 (0.971–2.002) m2/mL | 0.072 | |||
| RBC | 1.186 (1.036–1.358) kg/mL | 0.014 | |||
| Area CVP > 5 mmHg | 1.000 (1.000–1.001) (mmHg·min)−1 | 0.100 | |||
| Combined | 0.82 (0.66–0.94) | Area SpO2 < 90% | 0.983 (0.941–1.026) (%·min)−1 | 0.423 | |
| Serum direct bilirubin | 2.834 (1.274–6.302) dL/mg | 0.011 | |||
| MAD CVP | 0.320 (0.116–0.879) mmHg−1 | 0.027 | |||
| Area CVP > 5 mmHg | 1.001 (1.000–1.001) (mmHg·min)−1 | 0.005 | |||
| Serum total bilirubin | 0.574 (0.323–1.019) dL/mg | 0.058 | |||
| Blood product volumes and duration | 0.72 (0.45–0.87) | Whole blood | 1.117 (1.019–1.225) kg/mL | 0.018 | |
| Fresh frozen plasma | 0.966 (0.896–1.042) kg/mL | 0.374 |
AUC: area under the receiver operating characteristic curve; CI: confidence interval. For abbreviations in feature names, see Table 2.
Figure 2Frequency that features are included at a significant level (P < 0.05) in classifiers with AUC greater than 0.7. (A) Results from 180-day mortality classifiers that used only intraoperative features and (B) that used both pre- and intraoperative features. (C) Results from ARF classifiers that used only intraoperative features and (D) that used both pre- and intraoperative features. Dark shading indicates the fraction of classifiers in which the feature was included with odds ratio (OR) greater than 1 and light shading indicates OR less than 1. The monotone nature of each bar’s shading indicates that features always had ORs on the same side of 1, i.e., they were always associated with risk in the same direction. Features below the dashed line were never included at a significant level.